Tumor-infiltrating lymphocyte therapy has received approval from FDA for some patients with metastatic melanoma.
New cell-based immunotherapy offered for melanoma (Links to an external site)

Tumor-infiltrating lymphocyte therapy has received approval from FDA for some patients with metastatic melanoma.
A research team, including Ryan Fields, MD, has received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance, for a immunotherapy trial for melanoma.
Research projects will benefit from $1.5 million in new grants announced by Siteman Cancer Center.
Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer.
Funding aims to increase number of physicians driving innovative research in oncology
The Washington University campus community is making headlines every day. Members of the School of Medicine are regularly featured in local, national and international news stories. Department of Surgery faculty, staff and medical students are leaders in their specialties, and share their expertise when called upon. Campus Catch-Up collects some of these stories and celebrates members of the community who are receiving recognition.
The Washington University campus community is making headlines every day. Members of the School of Medicine are regularly featured in local, national and international news stories. Department of Surgery faculty, staff and medical students are leaders in their specialties, and share their expertise when called upon.